Page last updated: 2024-09-02

caffeic acid phenethyl ester and pomalidomide

caffeic acid phenethyl ester has been researched along with pomalidomide in 1 studies

Compound Research Comparison

Studies
(caffeic acid phenethyl ester)
Trials
(caffeic acid phenethyl ester)
Recent Studies (post-2010)
(caffeic acid phenethyl ester)
Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010) (pomalidomide)
8401469623121552

Protein Interaction Comparison

ProteinTaxonomycaffeic acid phenethyl ester (IC50)pomalidomide (IC50)
DNA damage-binding protein 1Homo sapiens (human)2.1
Protein cereblonHomo sapiens (human)1.85

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hogan, L; Kim, MJ; Lassalle-Claux, G; Luiker, K; Murugesan, A; Reiman, T; Selka, A; Touaibia, M; Vaillancourt, E1

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and pomalidomide

ArticleYear
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
    Journal of natural products, 2020, 12-24, Volume: 83, Issue:12

    Topics: Angiogenesis Inhibitors; Apoptosis; Caffeic Acids; Cell Line, Tumor; Down-Regulation; Genes, myc; Humans; Ikaros Transcription Factor; Interferon Regulatory Factors; Lenalidomide; Multiple Myeloma; Phenylethyl Alcohol; Sp1 Transcription Factor; Structure-Activity Relationship

2020